Evaluating the Role of PD1 and MTNR1B Gene Variants in Breast Cancer Susceptibility: A Case–Control Study in Bangladesh
Journal of Clinical Laboratory Analysis · 2025
DOI: 10.1002/jcla.70086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Farhan Jamil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Lab, Rufaida BioMeds, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rufaida BioMeds.
Abstract (Originalsprache)
Objectives
Breast cancer is one of the most common malignancies in women. The PD1 and MTNR1B gene polymorphisms have been extensively studied for their potential role in cancer susceptibility. This study aimed to investigate associations between breast cancer risk and PD1 (rs36084323) and MTNR1B (rs10830963) polymorphisms.
Methods
A case–control study was conducted with 112 breast cancer patients from Dhaka Cancer and General Hospital, Bangladesh, and 124 age‐ and sex‐matched healthy controls. Genotyping of PD1 (rs36084323) and MTNR1B (rs10830963) polymorphisms was performed using the Polymerase Chain Reaction–Restriction Fragment Length Polymorphism (PCR‐RFLP) method.
Results
The genotype distributions for both SNPs adhered to Hardy–Weinberg equilibrium (HWE). The PD1 GG genotype was more prevalent in controls, indicating a protective effect, whereas the GG genotype of MTNR1B showed no statistically significant association with breast cancer risk. The recessive model of PD1 (GG vs. AG + AA) demonstrated a lower odds ratio (0.2873), while the recessive model of MTNR1B (2.307) suggested a potential risk. Dominant models for both genes (AG + GG vs. AA for PD1 and CG + GG vs. CC for MTNR1B ) showed statistically significant associations with breast cancer susceptibility.
Conclusion
The PD1 GG genotype exhibited a significant protective effect against breast cancer, while the MTNR1B CG genotype was associated with reduced risk, but GG showed no correlation. Larger studies across diverse populations are recommended to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Lab, Rufaida BioMeds, Dhaka, Bangladesh.
- American International University-Bangladesh, Dhaka, Bangladesh.
- School of Pharmacy, BRAC University, Dhaka, Bangladesh.
ORCID-Profile: Mohammad Mahfuz Enam Elahi, Sakif Ahamed Khan, Md Aminul Haque
Förderung
- Rufaida BioMeds
Zitieren
APA
Jamil, F., Elahi, M. M. E., Evan, A. S., Khan, S. A., Annee, I. J., Furhatun-Noor, Islam, A., Tabassum, R., & Haque, M. A. (2025). Evaluating the Role of PD1 and MTNR1B Gene Variants in Breast Cancer Susceptibility: A Case–Control Study in Bangladesh. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70086
Vancouver
Jamil F, Elahi MME, Evan AS, Khan SA, Annee IJ, Furhatun-Noor, et al. Evaluating the Role of PD1 and MTNR1B Gene Variants in Breast Cancer Susceptibility: A Case–Control Study in Bangladesh. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70086
BibTeX
@article{Jamil2025,
author = {Jamil, Farhan and Elahi, Mohammad Mahfuz Enam and Evan, Al-Shahriar and Khan, Sakif Ahamed and Annee, Israt Jahan and Furhatun-Noor and Islam, Ankita and Tabassum, Rana and Haque, Md Aminul},
title = {Evaluating the Role of PD1 and MTNR1B Gene Variants in Breast Cancer Susceptibility: A Case–Control Study in Bangladesh},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
doi = {10.1002/jcla.70086}
}
EUVIMED